Compare Crispr Therapeutics AG (CRSP) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Warner Music Group Corp — how do they compare? Crispr Therapeutics AG trades at $50.52 (market cap $4.97B), while Warner Music Group Corp trades at $28.13 (market cap $14.38B). The key difference: Warner Music Group Corp is far larger — about 2.9× Crispr Therapeutics AG's market cap, and Warner Music Group Corp pays a 2.76% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | WMG | |
|---|---|---|
Market Cap | $4.97B | $14.38B |
Sector | Health | Media |
52-Week High | $76.78 | $34.72 |
52-Week Low | $44.34 | $23.65 |
Enterprise Value | $3.32B | $18.58B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRSP trades at $50.63, down 5.1% over 24 hours, amid a bearish technical signal. The company shows deep losses with a net income margin of -56,853.4% in 2025 and negative cash flow from operations. However, analyst consensus remains optimistic with a $74.50 price target, and recent news highlights FDA approval for Casgevy, expanding its gene therapy market.
The outlook hinges on commercial execution of Casgevy and pipeline progress, offering high growth potential in gene editing. Key risks include sustained cash burn, competitive pressures, and regulatory hurdles. Despite current financial challenges, strong analyst buy ratings suggest confidence in long-term value.
Warner Music Group (WMG) trades at $28.75, down 0.83% today, with a bullish technical signal and strong analyst consensus. Recent financials show revenue growth to $6.71B in 2025, though net income margin declined to 5.44%. The company maintains solid profitability with a 45.8% gross margin and recently acquired AI startup Sureel AI to enhance intellectual property management. Cash flow from operations remains healthy at $678M despite a net cash outflow of $159M in 2025.
WMG offers upside with a $40.40 consensus price target (40.5% potential) and 66.7% buy ratings, supported by streaming growth and AI initiatives. Risks include competitive pressures, margin volatility, and reliance on music industry trends. The stock's high P/E of 34.23 requires sustained earnings acceleration to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
